Nestlé announces results of tender offer for Aimmune Therapeutics, Inc.
Published By Nestlé [English], Mon, Oct 12, 2020 11:15 PM
Société des Produits Nestlé S.A. today announced the results of the tender offer by its wholly-owned subsidiary, SPN MergerSub, Inc., to purchase all of the outstanding shares of common stock of Aimmune Therapeutics, Inc., other than any Shares held by Nestlé and its affiliates, for a price of USD 34.50 per Share, net to the seller thereof in cash, without interest and subject to any withholding taxes, which was made upon the terms and subject to the conditions set forth in the Offer to Purchase and related Letter of Transmittal.
Press release distributed by Wire Association on behalf of Nestlé, on Oct 12, 2020. For more information subscribe and follow Nestlé